Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064

Expensive Performer

Download real time

922.90 23.60 (2.62%)

32.14% Fall from 52W High

92,838 NSE+BSE Volume

NSE 05 Sep, 2025 3:31 PM (IST)

35,307.1

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Cohance Lifesciences Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for COHANCE, BSE:543064 Cohance Lifesciences Ltd.

VOTE: Is Suven Pharmaceuticals Ltd. worth buying?

28 Votes:

Buy 67.86%

Sell 14.29%

Hold 17.86%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >